Search
for

    Sort by

    Research 331–360 of 1000+

    1. Wiederbehaarung bei einem Patienten mit Alopecia universalis und Psoriasis vulgaris unter Deucravacitinib‐Therapie JDDG Journal der Deutschen Dermatologischen Gesellschaft · 2025
    2. Alopecia Universalis: Never Give Up? PubMed · 2025
    3. Randomized Controlled Trial Study to Evaluate the Efficacy of Combination Therapy with Diphenylcyclopropenone and Platelet-Rich Plasmain Alopecia Areaata International Journal of Trichology · 2025
    4. Efficacy and safety of compound glycyrrhizin in patients with alopecia areata: a systematic review and meta-analysis Figshare · 2025
    5. Efficacy and safety of compound glycyrrhizin in patients with alopecia areata: a systematic review and meta-analysis Figshare · 2025
    6. Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy JDDG Journal der Deutschen Dermatologischen Gesellschaft · 2024
    7. Distribution of SALT Scores with Ritlecitinib Treatment up to 24 months from the ALLEGRO Phase 2b/3 and Long-Term Phase 3 Clinical Studies in Alopecia Areata SKIN The Journal of Cutaneous Medicine · 2024
    8. Combination Treatment with Methotrexate for Severe Alopecia Areata Journal of the Philippine Dermatological Society · 2024
    9. Treatment of Alopecia Areata using Transdermal Delivery of 5-Fluorouracil by Fractional CO2 Laser versus Intralesional Injection of 5-Fluorouracil Zagazig University Medical Journal · 2024
    10. Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata Journal of the European Academy of Dermatology and Venereology · 2024
    11. BH15 The burden of alopecia areata: examining baseline health-related quality of life and clinical assessment tools British Journal of Dermatology · 2024
    12. Real‐world effectiveness and safety of tofacitinib for alopecia areata: A retrospective cohort study of 202 patients Australasian Journal of Dermatology · 2024
    13. Determining meaningful thresholds for evaluating treatment efficacy in patients with alopecia areata JEADV Clinical Practice · 2024
    14. Safety and efficacy of tofacitinib in 97 alopecia areata patients Journal of cosmetic dermatology · 2024
    15. The Efficacy of Baricitinib as a Treatment Option for Alopecia, In Terms of Promoting Hair Regrowth and Improving Patient Reported Outcomes 2024
    16. Disease burden, clinical management and unmet treatment need of patients with moderate to severe alopecia areata; consensus statements, insights, and practices from CERTAAE (Central/Eastern EU, Russia, Türkiye AA experts) Delphi panel Frontiers in medicine · 2024
    17. Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis Frontiers in pharmacology · 2024
    18. Current Diagnostic and Therapeutic Practices in Alopecia Areata in Two Mediterranean Countries: A Survey-Based Study Dermatology and therapy · 2024
    19. Efficacy and Safety of Topical Corticosteroid Treatment under Occlusion for Severe Alopecia Areata in Children. A single-center retrospective analysis Clinical and experimental dermatology · 2024
    20. Real-World Assessment of Disease Characteristics and Clinical Outcomes in Alopecia Areata in a Global Noninterventional Observational Cohort (ADAAGIO) Skin · 2024
    21. Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata Dermatologic therapy · 2024
    22. Growth Factors and Microneedling in Alopecia Areata: A Narrative Review Skin appendage disorders · 2024
    23. Hairy tongue associated with the use of baricitinib therapy for ophiasis pattern alopecia areata JEADV Clinical Practice · 2023
    24. Efficacy of Oral Apremilast in The Treatment of Alopecia Areata, at The Tertiary Care Hospital, Karachi Journal of health and rehabilitation research · 2023
    25. Upadacitinib for the treatment of alopecia areata – A case report 2023
    26. Distribution of SALT scores by Therapeutic Tesponse in Patients with Severe Alopecia After 52 weeks of Baricitinib Therapy Skin · 2023
    27. Sustained Scalp, Eyebrow, and Eyelash Hair Regrowth with Ritlecitinib Through Week 48 in Patients with Alopecia Areata: Post-Hoc Analysis of the ALLEGRO Phase 2b/3 Study SKIN The Journal of Cutaneous Medicine · 2023
    28. Outcomes of Down-Titration in Patients With Severe Scalp Alopecia Areata Treated With Baricitinib: An Update Through Week 152 From BRAVE-AA2 Skin · 2023
    29. Alopecia areata: Ritlecitinib generates substantial re-growth of scalp hair 2023
    30. Effectiveness of Tofacitinib in Pre-adolescent Alopecia Areata: A Retrospective Case Series and Literature Review Acta dermato-venereologica · 2023